Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin vs Azithromycin for PPROM
NCT06273891Phase 3Active, not recruiting
- Sponsor
- Inova Health System
- Start
- Mar 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin, erythromycin in premature rupture of membranes (PROM), sponsored by Inova Health System. Started Mar 2024; status: active, not recruiting.
02
Drugs
azithromycinerythromycin
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT06273891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06273891.